and BAGSVRD, Denmark, Nov
Brand-name tirzepatide (Mounjaro, Zepbound) Eli Lilly manufactures brand-name tirzepatide in prefilled injection pens with extensive stability testing

Strengths Highly polished, user-friendly app and online experience Strong brand recognition and marketing presence Available in all 50 states Vertically integrated pharmacy operations improving supply reliability Competitive pricing, especially for multi-month commitments Both semaglutide and tirzepatide options available Broad product ecosystem - can address multiple health needs through one platform Considerations Uses a mix of 503A and 503B pharmacies without clear disclosure of which fills your specific order Clinical support depth may not match more medically focused platforms The consumer-product approach may feel too transactional for patients wanting a more clinical relationship Multi-month commitments may be required for best pricing, reducing flexibility Brand-name Wegovy options are limited compared to platforms like Ro or Calibrate Best For Patients who value a sleek, technology-forward experience and strong brand trust

Retatrutide by itself produces acceptable body composition outcomes, with most weight lost coming from fat
Although GLP-1RAs are generally well tolerated and considered safe drugs, as they gain widespread use for obesity, rare but serious adverse effects such as gastroparesis, bowel obstruction, pancreatitis and non-arteritic anterior ischemic optic neuropathy are emerging